Cancer Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Cancer stocks.

Cancer Stocks Recent News

Date Stock Title
Jun 1 AFL Aflac Incorporated's (NYSE:AFL) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
May 31 AZN Ontario court approves AstraZeneca/Fusion acquisition plan
May 31 AZN The Most Profitable Biotechnology Company in the World
May 31 GSK Moderna Looks for Boost From Newly Approved RSV Shot
May 31 AZN Pfizer (PFE) Up 1.8% Since Last Earnings Report: Can It Continue?
May 31 AFL Aflac (AFL) Up 4.7% Since Last Earnings Report: Can It Continue?
May 31 AMED Amedisys falls amid report divestiture buyer in UnitedHealth deal is gone
May 31 AZN AstraZeneca CEO Has No Plans to Retire as He Seeks to Nearly Double Sales by 2030
May 31 MYGN QIAGEN (QGEN) Develops Test for Research and CDx Application
May 31 AZN Pharma Stock Roundup: JNJ, MRK M&A Deals, SNY, RHHBY Drugs' Priority Review & More
May 30 MYGN QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications
May 30 GSK Third human bird flu case found in U.S.
May 30 AFL Aflac Voices - Jeri Hawthorne: Cultivating Mental Wellness at Work
May 30 TEVA Teva wins FDA nod for new Austedo formulation
May 30 AZN This Pharma Stock Is Poised to Keep Outperforming the S&P 500
May 30 TEVA FDA approves Teva Pharmaceuticals’ AUSTEDO XR for TD and HD chorea
May 30 AZN Goldman Sachs Says Buy European Pharma Stocks Touting Innovation
May 29 TEVA Teva Announces AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets Now U.S. FDA Approved as a One Pill, Once-Daily Treatment Option for Clinically Therapeutic Doses (24–48 mg/day)
May 29 AZN Fusion shareholders give green light to AstraZeneca acquisition
May 29 AZN Amgen wins approval of first biosimilar of AstraZeneca's Soliris
Cancer

Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. These contrast with benign tumors, which do not spread to other parts of the body. Possible signs and symptoms include a lump, abnormal bleeding, prolonged cough, unexplained weight loss and a change in bowel movements. While these symptoms may indicate cancer, they may have other causes. Over 100 types of cancers affect humans.Tobacco use is the cause of about 22% of cancer deaths. Another 10% are due to obesity, poor diet, lack of physical activity or excessive drinking of alcohol. Other factors include certain infections, exposure to ionizing radiation and environmental pollutants. In the developing world, 15% of cancers are due to infections such as Helicobacter pylori, hepatitis B, hepatitis C, human papillomavirus infection, Epstein–Barr virus and human immunodeficiency virus (HIV). These factors act, at least partly, by changing the genes of a cell. Typically, many genetic changes are required before cancer develops. Approximately 5–10% of cancers are due to inherited genetic defects from a person's parents. Cancer can be detected by certain signs and symptoms or screening tests. It is then typically further investigated by medical imaging and confirmed by biopsy.Many cancers can be prevented by not smoking, maintaining a healthy weight, not drinking too much alcohol, eating plenty of vegetables, fruits and whole grains, vaccination against certain infectious diseases, not eating too much processed and red meat and avoiding too much sunlight exposure. Early detection through screening is useful for cervical and colorectal cancer. The benefits of screening in breast cancer are controversial. Cancer is often treated with some combination of radiation therapy, surgery, chemotherapy and targeted therapy. Pain and symptom management are an important part of care. Palliative care is particularly important in people with advanced disease. The chance of survival depends on the type of cancer and extent of disease at the start of treatment. In children under 15 at diagnosis, the five-year survival rate in the developed world is on average 80%. For cancer in the United States, the average five-year survival rate is 66%.In 2015, about 90.5 million people had cancer. About 14.1 million new cases occur a year (not including skin cancer other than melanoma). It caused about 8.8 million deaths (15.7% of deaths). The most common types of cancer in males are lung cancer, prostate cancer, colorectal cancer and stomach cancer. In females, the most common types are breast cancer, colorectal cancer, lung cancer and cervical cancer. If skin cancer other than melanoma were included in total new cancer cases each year, it would account for around 40% of cases. In children, acute lymphoblastic leukemia and brain tumors are most common, except in Africa where non-Hodgkin lymphoma occurs more often. In 2012, about 165,000 children under 15 years of age were diagnosed with cancer. The risk of cancer increases significantly with age, and many cancers occur more commonly in developed countries. Rates are increasing as more people live to an old age and as lifestyle changes occur in the developing world. The financial costs of cancer were estimated at $1.16 trillion USD per year as of 2010.

Browse All Tags